NCT03978546

Brief Summary

Early glaucomatous visual field changes can be missed with the routinely used Standard Automated Perimetry (SAP) and the 24-2 test pattern due to limited sampling of the central 10 degrees. While this shortcoming can be overcome with the addition of a 10-2 test, performing both tests places extra demand on the perimetric services (doubling test times) and patients. Smart Supra Perimetry (SSP) uses a new faster algorithm that can complete both 24-2 and 10-2 test patterns in a similar time frame to a single 24-2 SAP test. This comparative study aims to determine the sensitivity and specificity (i.e. diagnostic accuracy) of SSP in identifying early glaucomatous visual field loss. A sample of 100 patients with early/suspect glaucoma will undergo SAP 24-2 and 10-2 (SITA algorithm) using Humphrey visual field perimetry and SSP 24+10-2 using Henson 9000. Eyes will be categorised into 2 groups i.e., glaucoma and non-glaucoma, on the basis of structural changes to the disc as evaluated by the clinician. The sensitivity and specificity of the SAP and SSP tests will be established along with test duration. The size and location of defects established with both the SAP and SSP strategies will also be compared.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2019

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 7, 2019

Completed
4 days until next milestone

Study Start

First participant enrolled

June 11, 2019

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

August 31, 2022

Status Verified

August 1, 2022

Enrollment Period

2.8 years

First QC Date

May 16, 2019

Last Update Submit

August 30, 2022

Conditions

Keywords

glaucoma

Outcome Measures

Primary Outcomes (1)

  • Diagnostic performance of smart supra perimetry

    Area under the curve for Smart Suprathrold Perimetry using probability thresholds to differentiate early glaucoma from non-glaucomatous visual fields.

    12 months

Secondary Outcomes (2)

  • Diagnostic performance of Optical Coherent Tomography

    12 months

  • Diagnostic performance of Standard Automated perimetry

    12 months

Study Arms (2)

Non-Glaucoma Patient Arm

EXPERIMENTAL

All participants will complete the same assessments

Diagnostic Test: Humphrey Visual Field TestDiagnostic Test: Optical Coherence Tomography (OCT) ScanDiagnostic Test: Smart Perimetry - Henson 9000

Glaucoma Patient Arm

EXPERIMENTAL

All participants will complete the same assessments

Diagnostic Test: Humphrey Visual Field TestDiagnostic Test: Optical Coherence Tomography (OCT) ScanDiagnostic Test: Smart Perimetry - Henson 9000

Interventions

SITA Standard and 24-2 and 10-2 visual field tests

Glaucoma Patient ArmNon-Glaucoma Patient Arm

Circle and Wide Angle Scans

Glaucoma Patient ArmNon-Glaucoma Patient Arm

24+10-2 Smart Supra test

Glaucoma Patient ArmNon-Glaucoma Patient Arm

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Reliable SAP visual field results (fixation loss \< 33%, false positive \< 15% and false negative \< 20%).
  • Visual acuity better or equal to 0.20 logMAR.
  • Spherical refractive error within -6.00 to +6.00D and cylindrical error \<2.00D
  • No ocular co-morbidity likely to affect the visual field or OCT results.
  • Age: 40-80 yrs
  • Optic disc showing glaucomatous changes.
  • SAP MD not worse than -6dB
  • Normal SAP visual field data (MD, PSD, GHT within normal range)
  • No evidence of glaucoma or other Ocular co-morbidity in the eye suitable for the study.

You may not qualify if:

  • Anomalous discs, Tilted discs, myopic discs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Manchester Royal Eye Hospital

Manchester, M13 9WL, United Kingdom

Location

Related Publications (1)

  • Sukumar S, Harper RA, Tsamis E, Hood D, Henson DB. Diagnostic Accuracy of Smart Supra Perimetry in Comparison With Standard Automated Perimetry in the Detection of Early Glaucoma. J Glaucoma. 2025 Sep 1;34(9):710-718. doi: 10.1097/IJG.0000000000002596. Epub 2025 May 14.

MeSH Terms

Conditions

Ocular HypertensionGlaucoma

Interventions

Tomography, Optical CoherenceRadionuclide Imaging

Condition Hierarchy (Ancestors)

Eye Diseases

Intervention Hierarchy (Ancestors)

Tomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative TechniquesDiagnostic Techniques, Radioisotope

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
FACTORIAL
Model Details: All participants will have the same examinations but in a randomised order, these examinations are: Humphrey Visual Fields Test (10-2 and 24-2, SITA Standard), OCT Scan (Cube scan, Wide angle and macula scan) and Smart Perimetry - Henson 9000.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2019

First Posted

June 7, 2019

Study Start

June 11, 2019

Primary Completion

March 31, 2022

Study Completion

March 31, 2022

Last Updated

August 31, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations